Non-HCV co-infected group | HCV co-infected group | |||||
---|---|---|---|---|---|---|
Untreated | NNRTI | PI | Untreated | NNRTI | PI | |
( n = 19) | ( n = 32) | ( n = 25) | ( n = 32) | ( n = 44) | ( n = 39) | |
FASN, μg/L | 5.14 (2.10) | 7.40 (1.81) | 4.15 (1.00) | 20.01 (4.0) | 8.64 (1.51) b | 11.75 (2.41) a |
NEFA, mmol/L | 0.53 (0.07) | 0.63 (0.07) | 0.77 (0.1) | 0.65 (0.06) | 0.67 (0.05) * | 0.52 (0.04) |
Glucose, mmol/L | 5.21 (0.20) | 5.77 (0.29) * | 5.09 (0.09) | 5.13 (0.13) | 5.62 (0.19) a | 5.21 (011) |
Insulin, pmol/L | 41.91 (7.1) | 70.74 (13.4) a | 62.23 (8.6) a | 71.35 (11.2) | 103.2 (19.8) | 72.24 (10.7) |
HOMA-IR | 0.80 (0.16) | 1.38 (0.27) a | 1.14 (0.16) | 1.41 (0.25) | 2.06 (0.42) | 1.36 (0.21) |
Cholesterol, mmol/L | 4.59 (0.24) | 5.34 (0.23) a,* | 6.10 (0.28) c | 4.41 (0.19) | 4.67 (0.23) | 4.7 (0.16) |
HDL-cholesterol, mmol/L | 1.18 (0.09) | 1.30 (0.12) | 1.18 (0.10) | 1.17 (0.07) | 1.20 (0.05) * | 1.09 (0.6) |
LDL-cholesterol, mmol/L | 2.69 (0.22) | 3.10 (0.20) * | 3.59 (0.23) a | 2.57 (0.15) | 2.54 (0.18) | 2.70 (1.15) |
Triglyceride, mmol/L | 1.57 (0.29) | 2.60 (0.44) a | 4.87 (1.50) b | 2.99 (1.71) | 2.35 (0.36) a | 2.17 (0.22) b |
Apolipoprotein AI, g/L | 1.39 (0.06) | 1.43 (0.07) | 1.34 (0.06) | 1.33 (0.06) | 1.45 (0.04) * | 1.32 (0.04) |
Alanine aminotransferase, μKat/L | 0.52 (0.10) | 0.57 (0.11) | 0.45 (0.06) | 1.16 (0.16) | 0.91 (0.11) | 0.69 (0.07) a |
Aspartate aminotransferase, μKat/L | 0.45 (0.07) | 0.45 (0.04) | 0.41 (0.08) | 1.02 (0.13) | 0.94 (0.14) | 0.69 (0.07) a |